Petru I.
- Country
- Romania
- Department
- Psychiatry
Research Overview
- Evaluation of the Efficacy and Safety of Trospium Chloride and Xanomeline Tartrate in Treating Manic Episodes in Bipolar-I Disorder: A Phase 3 Randomized Study
- Long-term Safety and Tolerability Evaluation of Trospium Chloride and Xanomeline Tartrate in Agitation Associated with Alzheimer's Disease
- Evaluation of the Safety and Efficacy of Trospium Chloride and Xanomeline Tartrate in Treating Agitation in Alzheimer's Disease: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 42 of 121 partner sites.
Specializations
Psychiatric Disorders
The investigator specializes in the treatment and research of schizophrenia, with particular focus on managing acute psychotic episodes and developing innovative therapeutic approaches.
- Acute Psychosis Management
- Treatment-Resistant Schizophrenia
- Antipsychotic Therapy
The investigator evaluates novel therapeutic agents for patients with inadequate response to conventional treatments.
Therapeutic Innovation
Research activities center on adjunctive treatment approaches and the development of new therapeutic options for psychiatric disorders.
- Novel Pharmaceutical Compounds
- Combination Therapy Strategies
- Treatment Optimization
Focus includes evaluation of innovative compounds for enhanced therapeutic outcomes in psychiatric conditions.
Clinical Assessment
Expertise in utilizing standardized assessment tools including the Positive and Negative Syndrome Scale (PANSS) for evaluating treatment efficacy.
- Symptom Assessment
- Treatment Response Monitoring
- Safety and Tolerability Evaluation
Specializes in comprehensive evaluation of therapeutic interventions for psychiatric conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.